Charles Douglas Blundell
Fondatore presso C4X Discovery Ltd.
Posizioni attive di Charles Douglas Blundell
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Direttore/Membro del Consiglio | 01/01/2008 | - |
| Direttore Tecnico/Scientifico/R&S | 23/11/2009 | - | |
| Fondatore | 23/11/2009 | - |
Storia della carriera di Charles Douglas Blundell
Precedenti posizioni note di Charles Douglas Blundell
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| C4X DISCOVERY HOLDINGS PLC | Direttore Tecnico/Scientifico/R&S | 01/01/2008 | - |
| Fondatore | 01/01/2008 | - |
Formazione di Charles Douglas Blundell
| University of Oxford | Doctorate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 4 |
Posizioni
| Founder | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| C4X DISCOVERY HOLDINGS PLC | Health Technology |
| Aziende private | 1 |
|---|---|
C4X Discovery Ltd.
C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Health Technology |
